The G protein-coupled receptor 152 (GPR152) is a poorly characterized member of the GPCR superfamily, a large group of transmembrane proteins involved in signal transduction and cellular communication. Classified as an orphan receptor due to its unknown endogenous ligand, GPR152 is encoded by a gene located on human chromosome 12. It shares structural features with other GPCRs, including seven transmembrane domains, but its physiological role remains unclear. Limited studies suggest potential involvement in neuroendocrine regulation, metabolic processes, or circadian rhythm modulation, though functional data are sparse.
GPR152 antibodies are essential tools for investigating its expression, localization, and function. These antibodies, often raised against synthetic peptides or recombinant protein fragments (e.g., extracellular or intracellular domains), enable detection via techniques like Western blotting, immunohistochemistry, or flow cytometry. Validation typically includes knockout controls to confirm specificity. Commercial antibodies vary in host species (rabbit, mouse) and clonality (monoclonal/polyclonal). Challenges include low endogenous expression levels and potential cross-reactivity with homologous GPCRs.
Research applications focus on mapping GPR152 distribution in tissues (e.g., brain, pancreas) and exploring its role in diseases like diabetes or neurological disorders. Recent interest lies in de-orphanization efforts and its potential as a therapeutic target. Reliable antibodies are critical for advancing understanding of GPR152's signaling mechanisms and pathophysiological relevance.